These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15253741)

  • 21. [Multi-frequency low-dose intravenous iron on oxidative stress in maintenance hemodialysis patients].
    Yin L; Chen X; Chen J; Cheng M; Peng Y; Yang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):844-8. PubMed ID: 22954919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The redox state of albumin and serious cardiovascular incidence in hemodialysis patients.
    Terawaki H; Takada Y; Era S; Funakoshi Y; Nakayama K; Nakayama M; Ogura M; Ito S; Hosoya T
    Ther Apher Dial; 2010 Oct; 14(5):465-71. PubMed ID: 21175544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D receptor activator reduces oxidative stress in hemodialysis patients with secondary hyperparathyroidism.
    Tanaka M; Tokunaga K; Komaba H; Itoh K; Matsushita K; Watanabe H; Kadowaki D; Maruyama T; Otagiri M; Fukagawa M
    Ther Apher Dial; 2011 Apr; 15(2):161-8. PubMed ID: 21426509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of parenteral iron therapy and oral vitamin E supplementation on neutrophil respiratory burst in chronic hemodialysis patients.
    Hodkova M; Dusilova-Sulkova S; Skalicka A; Kalousova M; Zima T; Bartunkova J
    Ren Fail; 2005; 27(2):135-41. PubMed ID: 15807176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does treatment of renal anemia with recombinant erythropoietin influence oxidative stress in hemodialysis patients?
    Sommerburg O; Grune T; Hampl H; Riedel E; Ehrich JH; Siems WG
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S23-9. PubMed ID: 10746802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pomegranate juice intake attenuates the increase in oxidative stress induced by intravenous iron during hemodialysis.
    Shema-Didi L; Kristal B; Ore L; Shapiro G; Geron R; Sela S
    Nutr Res; 2013 Jun; 33(6):442-6. PubMed ID: 23746559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbonyl stress induced by intravenous iron during haemodialysis.
    Michelis R; Gery R; Sela S; Shurtz-Swirski R; Grinberg N; Snitkovski T; Shasha SM; Kristal B
    Nephrol Dial Transplant; 2003 May; 18(5):924-30. PubMed ID: 12686666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High iron storage levels are associated with increased DNA oxidative injury in patients on regular hemodialysis.
    Yoshimura K; Nakano H; Yokoyama K; Nakayama M
    Clin Exp Nephrol; 2005 Jun; 9(2):158-63. PubMed ID: 15980952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of the iron metabolism and effectiveness of anemia treatment in patients on maintenance hemodialysis performed based on polysulfone and helixone dialyzers].
    Sobaszek-Pitas M; Krzanowska K; Sułowicz W
    Przegl Lek; 2014; 71(8):418-22. PubMed ID: 25546912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
    Marsillach J; Martínez-Vea A; Marcas L; Mackness B; Mackness M; Ferré N; Joven J; Camps J
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):347-9. PubMed ID: 17324148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients.
    Schaller G; Scheiber-Mojdehkar B; Wolzt M; Puttinger H; Mittermayer F; Hörl WH; Födinger M; Sunder-Plassmann G; Vychytil A
    Kidney Int; 2005 Dec; 68(6):2814-22. PubMed ID: 16316358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
    Swarnalatha G; Ram R; Neela P; Naidu MU; Dakshina Murty KV
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbonyl stress in chronic renal failure: the effect of haemodialysis.
    Dursun E; Dursun B; Süleymanlar G; Ozben T
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):64-6. PubMed ID: 15802036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients.
    Tarng DC; Huang TP; Liu TY; Chen HW; Sung YJ; Wei YH
    Kidney Int; 2000 Aug; 58(2):790-9. PubMed ID: 10916104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-mercaptalbumin, Oxidized Form of Serum Albumin, Significantly Associated with Renal Function and Anemia in Chronic Kidney Disease Patients.
    Nakatani S; Yasukawa K; Ishimura E; Nakatani A; Toi N; Uedono H; Tsuda A; Yamada S; Ikeda H; Mori K; Emoto M; Yatomi Y; Inaba M
    Sci Rep; 2018 Nov; 8(1):16796. PubMed ID: 30429539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.
    Frankenfield D; Johnson CA; Wish JB; Rocco MV; Madore F; Owen WF
    Kidney Int; 2000 Feb; 57(2):578-89. PubMed ID: 10652035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of telmisartan on ambulatory blood pressure monitoring, plasma brain natriuretic peptide, and oxidative status of serum albumin in hemodialysis patients.
    Shimada H; Kitamura K; Anraku M; Miyoshi T; Adachi M; Tuyen DG; Wakamatsu S; Nonoguchi H; Tanaka M; Tomita K
    Hypertens Res; 2005 Dec; 28(12):987-94. PubMed ID: 16671338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical evaluation of serum albumin reductivity in patients with renal dysfunction: a comparison between conservative renal failure patients and hemodialysis patients].
    Suzuki Y; Aoki Y; Matsuyama Y; Hasegawa H; Shinohara Y; Hashimoto T; Era S; Soejima A
    Nihon Jinzo Gakkai Shi; 2008; 50(4):513-20. PubMed ID: 18546883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients.
    Hsu SP; Chiang CK; Yang SY; Chien CT
    Nephron Clin Pract; 2010; 116(3):c207-16. PubMed ID: 20606481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.